J2277 – Injection, motixafortide, 0.25 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ2277
- Long description
- Injection, motixafortide, 0.25 mg
- Short description
- Inj, motixafortide, 0.25 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- April 1, 2024
- Last change
- April 1, 2024 – No change
Frequently asked questions
What is HCPCS code J2277?
J2277 is a HCPCS Level II code for injection, motixafortide, 0.25 mg.
Does Medicare cover J2277?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J2260 – Injection, milrinone lactate, 5 mg
- J2265 – Injection, minocycline hydrochloride, 1 mg
- J2267 – Injection, mirikizumab-mrkz, 1 mg
- J2270 – Injection, morphine sulfate, up to 10 mg
- J2271 – Injection, morphine sulfate, 100mg
- J2272 – Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg
- J2274 – Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
- J2275 – Injection, morphine sulfate (preservative-free sterile solution), per 10 mg
- J2278 – Injection, ziconotide, 1 microgram
- J2280 – Injection, moxifloxacin, 100 mg
- J2281 – Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg
- J2290 – Injection, nafcillin sodium, 20 mg
- J2291 – Injection, nafcillin sodium (baxter), 20 mg
- J2300 – Injection, nalbuphine hydrochloride, per 10 mg
- J2305 – Injection, nitroglycerin, 5 mg
- J2310 – Injection, naloxone hydrochloride, per 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.